Saitama, Japan

Koichiro Hagihara


Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 116(Granted Patents)


Location History:

  • Itami, JP (1988)
  • Kawagoe, JP (1992)
  • Saitama, JP (1990 - 1993)
  • Miyoshimachi, JP (1994)
  • Ohimachi, JP (1997 - 2000)

Company Filing History:


Years Active: 1988-2000

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Koichiro Hagihara

Introduction: Koichiro Hagihara, an esteemed inventor based in Saitama, Japan, has made significant strides in the field of pharmaceuticals, holding a remarkable total of 12 patents. His work primarily focuses on indazole compounds that are designed to address various medical conditions, particularly those related to the digestive system.

Latest Patents: Among his latest inventions are two notable patents: one for an indazole compound containing a monocyclic amine structure and another for indazole derivatives featuring a piperazinyl moiety. The latter patent highlights a 5-HT4 receptor agonist, which has proven to be useful in the treatment of digestive tract disorders, showcasing his dedication to improving healthcare options.

Career Highlights: Koichiro Hagihara has been instrumental in advancing research and development within the pharmaceutical industry while working at Nisshin Flour Milling Co., Ltd. His innovative mindset and focus on practical applications have established him as a key figure in the scientific community, particularly in Japan.

Collaborations: Throughout his career, Hagihara has collaborated with distinguished colleagues like Haruhiko Kikuchi and Hiroaki Satoh. These partnerships have allowed him to combine expertise and insights, ultimately enriching his contributions to the field and pushing the boundaries of what is achievable in pharmaceutical innovations.

Conclusion: Koichiro Hagihara's contributions to the realm of pharmaceutical inventions reflect his profound commitment to enhancing medical treatments. With a solid patent portfolio and a dedication to collaboration, he continues to inspire innovation and progress in the industry, making strides that could potentially benefit many individuals suffering from digestive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…